Literature DB >> 8786139

Genomic structure and precise mapping of a thymic regulatory region on mouse chromosome 17 revealed by a c-myc transgene insertion.

A Lavenu1, J Roland, C Poirier, P Cazenave, C Babinet, D Morello.   

Abstract

In one transgenic strain harboring a human c-myc proto-oncogene construct, the transgene was actively and exclusively expressed in the thymus, where it contributed to the development of lymphoma that corresponded to CD4(+)CD8(+) cells. Here, we have pursued the analysis of transgene expression in healthy transgenic mice and show that transgene activation occurs in the thymus 3 days before birth, at a time when CD4(+)CD8(+) lymphocytes emerge. In the adult, its expression is restricted to the CD4(+)CD8(+) cells. The region flanking the transgene insertion site was isolated and made it possible to map the preintegration locus, hereafter called Tsil (for thymus-specific integration locus) on chromosome 17 between D17Rp11e and Ras12-3. A YAC that contains both Tsil and the Pim2 locus, previously shown to be involved in progression of T-cell lymphoma, was isolated. Analysis of Tsil offers a unique opportunity to identify a regulatory region or a gene that might play an important role in T-cell maturation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786139     DOI: 10.1006/geno.1996.0301

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  2 in total

1.  Integration of H-2Z1, a somatosensory cortex-expressed transgene, interferes with the expression of the Satb1 and Tbc1d5 flanking genes and affects the differentiation of a subset of cortical interneurons.

Authors:  Nicolas Narboux-Nême; Rosette Goïame; Marie-Geneviève Mattéi; Michel Cohen-Tannoudji; Marion Wassef
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

2.  Exon 2-mediated c-myc mRNA decay in vivo is independent of its translation.

Authors:  S Pistoi; J Roland; C Babinet; D Morello
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.